You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
25 April 2024
Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.
23 April 2024
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
18 April 2024
Redcare Pharmacy’s Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.
4 April 2024
Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.
5 March 2024
Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.
4 March 2024
Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).
Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.
2 February 2024
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
10 January 2024
Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.
31 October 2023
Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.
5 October 2023
Redcare Pharmacy continues to successfully grow fast in all its markets.
9 August 2023
Redcare Pharmacy N.V.: Jasper Eenhorst, Sale of shares resulting from the exercise of a stock option plan.
Redcare Pharmacy N.V.: Jasper Eenhorst, Acquisition through exercise of stock options
1 August 2023
Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.
6 July 2023
Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth.
13 June 2023
Welcome, Redcare Pharmacy: Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today.
6 June 2023
SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.
22 May 2023
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.
17 May 2023
SHOP APOTHEKE EUROPE N.V.: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
11 May 2023
Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.
SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted
8 May 2023
SHOP APOTHEKE EUROPE N.V.: Marc Michael Fischer , sell
2 May 2023
SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.
27 April 2023
Successful Outcome for SHOP APOTHEKE EUROPE’s Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.
5 April 2023
SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.
3 April 2023
SHOP APOTHEKE EUROPE N.V.: Theresa Margarete Holler , sell
30 March 2023
SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.
SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.
30
Jul 24
Publication half-yearly financial report
05
Nov 24
Publication quarterly statement (call-date Q3)
investors@redcare-pharmacy.com